Keros Therapeutics
KROS
KROS
152 hedge funds and large institutions have $1.44B invested in Keros Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 40 reducing their positions, and 17 closing their positions.
Holders
152
Holders Change
+5
Holders Change %
+3.4%
% of All Funds
2.21%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
23
Increased
64
Reduced
40
Closed
17
Calls
$1.75M
Puts
$86K
Net Calls
+$1.66M
Net Calls Change
-$282K
Top Buyers
| 1 |
1
BlackRock
New York
|
$115M |
| 2 |
JFG
2
Jefferies Financial Group
New York
|
$41.1M |
| 3 |
3
Goldman Sachs
New York
|
$23.8M |
| 4 |
B
4
Braidwell
Stamford,
Connecticut
|
$44.9M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$80.3M |
